PIK3CA and breast cancer: Notably, TP53 shows a significantly higher mutation frequency in TNBC (80%) compared to other breast cancer (BC) subtypes (23%), while PIK3CA exhibits a lower mutation frequency in TNBC (15%) compared to nTNBC (40.3%).